Related Experiment Videos

Optimizing treatment for chronic congestive heart failure in children

R E Shaddy1

  • 1University of Utah School of Medicine, and the Heart Transplant Program, Primary Children's Medical Center, Salt Lake City, UT, USA.

Critical Care Medicine
|October 11, 2001
PubMed

Insights

Current pediatric chronic heart failure treatments are based on adult data. More research is needed to confirm the effectiveness of these medications in children, as their conditions often differ significantly from adults.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Research
  • Pharmacology in Children

Background:

  • Pediatric chronic heart failure (CHF) treatment strategies are often adapted from adult guidelines.
  • Existing knowledge and recommendations for adult CHF treatment are reviewed.
  • Limited specific data exists for pediatric CHF treatment.

Purpose of the Study:

  • To review current knowledge on adult CHF treatment.
  • To assess available information on pediatric CHF treatment.
  • To highlight the need for pediatric-specific clinical trials.

Main Methods:

  • Review of existing literature and treatment recommendations for adult CHF.
  • Analysis of anecdotal evidence for medication use in children.
  • Identification of knowledge gaps in pediatric CHF treatment.

Main Results:

  • Adult CHF medications include diuretics, digoxin, ACE inhibitors, and beta-blockers, based on robust trials.
  • Anecdotal evidence suggests potential benefits of these medications in children.
  • Significant differences in etiology, pathophysiology, and physiology between pediatric and adult CHF exist.

Conclusions:

  • Current pediatric CHF treatment relies heavily on extrapolated adult data.
  • Prospective, randomized trials are essential to evaluate medication efficacy specifically in children.
  • Such studies are critical for developing evidence-based pediatric CHF treatment guidelines.

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...